37 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among others. This Table of Contents 36 … review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals and policies agreed
ARS
2022 FY
CRBU
Caribou Biosciences Inc
28 Apr 23
Annual report to shareholders
12:00am
, ethnic characteristics, age), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among … to permit substantive review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals
DEF 14A
z4wyelhj 002hmp
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.38
vlirqqit iglzxmide
21 Mar 22
Annual report
4:19pm
10-K
EX-10.36
4qfaidsjusq mcb479
21 Mar 22
Annual report
4:19pm
10-K
eq9euyjk4 o7gcze5je
21 Mar 22
Annual report
4:19pm
10-K
EX-10.31
d0fwv2w61w3h6a7bey8r
21 Mar 22
Annual report
4:19pm
10-K
EX-10.34
5kardmjsl4f8bqga
21 Mar 22
Annual report
4:19pm
10-K
EX-10.40
0izx3oefx1qpb3a4 4yx
21 Mar 22
Annual report
4:19pm
8-K
EX-10.1
d6azga5u s61p13n
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
S-8
EX-99.6
ql0pkb2 nid
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.1
tfxj7e
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.2
mhxgbn qe44goq
26 Jul 21
Registration of securities for employees
4:15pm
424B4
mok06cao h83q5s5jj
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
EX-10.45
3n295jl85ndv c4y7
19 Jul 21
IPO registration (amended)
6:09am